Lesa Sroufe & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $654K | Hold |
2,599
| – | – | 0.47% | 38 |
|
|
2026
Q1 | $565K | Hold |
2,599
| – | – | 0.38% | 39 |
|
|
2025
Q4 | $594K | Hold |
2,599
| – | – | 0.44% | 37 |
|
|
2025
Q3 | $602K | Hold |
2,599
| – | – | 0.49% | 38 |
|
|
2025
Q2 | $482K | Hold |
2,599
| – | – | 0.44% | 42 |
|
|
2025
Q1 | $545K | Buy |
+2,599
| New | +$505K | 0.54% | 39 |
|
|
2024
Q3 | $513K | Hold |
2,599
| – | – | 0.48% | 40 |
|
|
2024
Q2 | $446K | Hold |
2,599
| – | – | 0.43% | 43 |
|
|
2024
Q1 | $473K | Hold |
2,599
| – | – | 0.44% | 42 |
|
|
2023
Q4 | $403K | Hold |
2,599
| – | – | 0.41% | 41 |
|
|
2023
Q3 | $387K | Hold |
2,599
| – | – | 0.42% | 43 |
|
|
2023
Q2 | $350K | Hold |
2,599
| – | – | 0.37% | 46 |
|
|
2023
Q1 | $414K | Hold |
2,599
| – | – | 0.42% | 44 |
|
|
2022
Q4 | $420K | Hold |
2,599
| – | – | 0.47% | 44 |
|
|
2022
Q3 | $349K | Buy |
+2,599
| New | +$373K | 0.42% | 49 |
|
|
2022
Q1 | $387K | Hold |
2,829
| – | – | 0.39% | 51 |
|
|
2021
Q4 | $383K | Hold |
2,829
| – | – | 0.38% | 51 |
|
|
2021
Q3 | $305K | Sell |
2,829
-490
| -15% | -$56K | 0.32% | 59 |
|
|
2021
Q2 | $374K | Buy |
3,319
+743
| +29% | +$83.7K | 0.37% | 54 |
|
|
2021
Q1 | $279K | Hold |
2,576
| – | – | 0.31% | 55 |
|
|
2020
Q4 | $276K | Hold |
2,576
| – | – | 0.33% | 57 |
|
|
2020
Q3 | $226K | Hold |
2,576
| – | – | 0.31% | 57 |
|
|
2020
Q2 | $253K | Buy |
+2,576
| New | +$227K | 0.34% | 52 |
|
|
2020
Q1 | – | Sell |
-2,404
| Closed | -$213K | – | 59 |
|
|
2019
Q4 | $213K | Buy |
+2,404
| New | +$200K | 0.2% | 59 |
|
|
2019
Q1 | – | Sell |
-2,279
| Closed | -$210K | – | 60 |
|
|
2018
Q4 | $210K | Hold |
2,279
| – | – | 0.18% | 54 |
|
|
2018
Q3 | $216K | Hold |
2,279
| – | – | 0.16% | 56 |
|
|
2018
Q2 | $211K | Buy |
2,279
+58
| +3% | +$5.66K | 0.16% | 57 |
|
|
2018
Q1 | $210K | Buy |
+2,221
| New | +$244K | 0.16% | 54 |
|
Other funds holding ABBV
Lesa Sroufe & Co's ABBV Position: Q2 2026 in Review
Lesa Sroufe & Co held its AbbVie (ABBV) position steady in Q2 2026 at 2,599 shares worth $654K. The position accounts for 0.47% of the portfolio, ranked #38.
Lesa Sroufe & Co first reported a position in ABBV in Q1 2018 and has held it in 28 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Lesa Sroufe & Co held 2,599 shares of AbbVie worth $654K as of Q2 2026.
- Lesa Sroufe & Co left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.47% of Lesa Sroufe & Co's portfolio in Q2 2026, its #38 holding.
- Lesa Sroufe & Co first reported a position in AbbVie in Q1 2018 and has held it in 28 quarters since.
- 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Lesa Sroufe & Co's 13F filing for Q2 2026, filed 22 Jul 2026.